(Q42987414)

English

Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients

scientific article published on September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients (English)

1 reference

Europe PubMed Central

12 November 2017

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Cheng PN

1

1 reference

Europe PubMed Central

12 November 2017

Marcellin P

2

1 reference

Europe PubMed Central

12 November 2017

Bacon B

3

1 reference

Europe PubMed Central

12 November 2017

Farrell G

4

1 reference

Europe PubMed Central

12 November 2017

Parsons I

5

1 reference

Europe PubMed Central

12 November 2017

Wee T

6

1 reference

Europe PubMed Central

12 November 2017

Chang TT

7

1 reference

Europe PubMed Central

12 November 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

12 November 2017

11

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

418-426

1 reference

Europe PubMed Central

12 November 2017

Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Meta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Structure of the human interferon alpha receptor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Treatment of chronic non-A non-B hepatitis with human interferon beta: a preliminary study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Nicotine metabolism varies between different ethnic groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Racial differences in HLA class II associations with hepatitis C virus outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00514.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2004.00514.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42987414&oldid=1975886682"